Proyeksi Harga City Therapeutics Inc(CTY) & Analisis Perusahaan - PER·Dividen·Kinerja·Target Harga·RSI·MACD | Saham AS Hari Ini
23 Okt pukul 4:00 PM ET (Korea 10/24 05:00)
Tabel metrik lengkap
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 39.99% | Shs Outstand | 50.3M | Perf Week | -7.28% |
| Market Cap | 1.07B | Forward P/E | - | EPS next Y | - | Insider Trans | 1.72% | Shs Float | 31.0M | Perf Month | - |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 11.39% | Short Float | - | Perf Quarter | - |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | - | Perf Half Y | - |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | - | Perf YTD | -9.7% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -13.02% ($23.88) | Perf Year | - |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 5.16% ($19.75) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.39% - | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.7 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | - | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -1.61% ($21.11) | Beta | - | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -1.61% ($21.11) | Rel Volume | 0.62 | Prev Close | $20.77 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -1.61% ($21.11) | Avg Volume(3M) | 0.55M | Price | $20.77 |
| IPO | 2026/10/16 | Option/Short | No/Yes | Trades | 1529 | Volume | 343,849 | Change | - |
City Therapeutics IncCTY | NASD | Biotechnology 🧬 리보핵산 간섭 기술로 질병과 관련된 단백질의 발현을 억제하는 차세대 치료제를 개발하는 임상 단계 바이오테크 기업입니다. 미국에 본사를 두고 있으며 혈전색전 질환, 스타가르트병 1형, 만성질환 빈혈을 겨냥한 파이프라인을 운영합니다. 최근 기업공개로 상장한 소형주입니다.
Dalam 1 tahun terakhir, cukup rendah
13% di bawah harga tertinggi 1 tahun.
Diperdagangkan lebih sedikit dari biasanya. Itu 62% dari volume rata-ratanya.
Kinerja jangka panjangnya cenderung datar
Ketuk untuk melihat angka
Tidak ada dividen
Belum ada laba untuk dibagikan.
Kepemilikannya biasa saja
Lembaga memiliki 11.4%.
Ketuk untuk melihat angka
Di sektor ini, merupakan perusahaan terbesar ke-153 dari 595
Berdasarkan kapitalisasi pasar $1B.
SPTXKe-149 Seaport Therapeutics Inc $1B PER - 
IMTXKe-150 Immatics N.V $1B PER - 
VORKe-151 Vor Biopharma Inc $1B PER - 
REPLKe-152 Replimune Group Inc $1B PER - CTYKe-153 City Therapeutics Inc $1B PER - 
Pertanyaan umum
Perusahaan seperti apa CTY?
CTY bergerak di sektor Healthcare dan industri Biotechnology.
Berapa kapitalisasi pasar CTY?
Kapitalisasi pasar CTY sekitar $1.1B, peringkat ke-2,524 di sektornya.
Berapa tertinggi dan terendah 52 minggu CTY?
CTY mencatat tertinggi $23.88 dan terendah $19.75 dalam 52 minggu terakhir.
